Collagen

Orphan designation: antisense oligonucleotide targeting exon 73 in the COL7A1 gene Treatment of epidermolysis bullosa, 12/10/2017 Withdrawn

Retrieved on: 
星期四, 四月 18, 2024
Eurostat, Diagnosis, Civil service commission, Gene, Mutation, Epidermolysis bullosa, Skin cancer, Patient, Committee, Knowledge, Regulation, Keratin, EMA, IRIS, Protein, Life expectancy, Deformity, Blister, European, Skin, Collagen, COMP, Infection, Sponsor, European Commission, Safety, Unit, Marketing, COL7A1, Medicine, Pharmaceutical industry

Orphan designation: antisense oligonucleotide targeting exon 73 in the COL7A1 gene Treatment of epidermolysis bullosa, 12/10/2017 Withdrawn

Key Points: 


Orphan designation: antisense oligonucleotide targeting exon 73 in the COL7A1 gene Treatment of epidermolysis bullosa, 12/10/2017 Withdrawn

Orphan designation: Tranilast Prevention of scarring post glaucoma filtration surgery, 27/07/2010 Positive

Retrieved on: 
星期四, 四月 18, 2024
Eurostat, Diagnosis, Civil service commission, Optic nerve, Brain, Pressure, Cell, Disease, Risk, Patient, Committee, Knowledge, Regulation, Cancer, EMA, IRIS, Scar, Eye, Wound healing, European, Allergic conjunctivitis, COMP, Collagen, Skin, European Commission, Safety, Glaucoma, Sclera, Pharmaceutical industry

Orphan designation: Tranilast Prevention of scarring post glaucoma filtration surgery, 27/07/2010 Positive

Key Points: 


Orphan designation: Tranilast Prevention of scarring post glaucoma filtration surgery, 27/07/2010 Positive

Orphan designation: Diacerein Treatment of epidermolysis bullosa, 20/02/2014 Positive

Retrieved on: 
星期四, 四月 18, 2024
Eurostat, Diagnosis, Civil service commission, Gene, Anthraquinones, Skin cancer, Epidermolysis bullosa, Disease, Inflammation, Patient, Committee, Knowledge, Regulation, Keratin, EMA, IRIS, Joint, Protein, Life expectancy, Deformity, Blister, Interleukin-1 family, Mouth, European, Skin, Collagen, COMP, Infection, Safety, European Commission, Pain, Osteoarthritis, Marketing, Swelling, FGK, Medicine, Pharmaceutical industry

Orphan designation: Diacerein Treatment of epidermolysis bullosa, 20/02/2014 Positive

Key Points: 


Orphan designation: Diacerein Treatment of epidermolysis bullosa, 20/02/2014 Positive

Mblue Labs Discovers Anti-Aging Power In Methylene Blue, Launches Bluelene Face&Neck Remodel Mask

Retrieved on: 
星期三, 三月 13, 2024
Scientific Reports, Health, Skin care, ECM, Face, Retinol, Radical (chemistry), Cell nucleus, Peptide, Extracellular matrix, DNA, Research, ROS, Mitochondrion, Methylene blue, Skin, Collagen, DNA repair, UMD, Identity matrix, Human, Ageing, Neck, Cosmetics

Bethesda, Maryland--(Newsfile Corp. - March 13, 2024) - Mblue Labs proudly announces the debut of the Face & Neck Remodel Mask, a groundbreaking addition to their renowned skincare brand, Bluelene.

Key Points: 
  • Bethesda, Maryland--(Newsfile Corp. - March 13, 2024) - Mblue Labs proudly announces the debut of the Face & Neck Remodel Mask, a groundbreaking addition to their renowned skincare brand, Bluelene.
  • Mblue Labs, a woman and minority-owned business, is dedicated to advancing skincare science, and this latest product embodies their commitment to unparalleled innovation.
  • Methylene Blue penetrates skin cells at the mitochondrial level, creating cell health and proliferation.
  • To view an enhanced version of this graphic, please visit:
    The Face & Neck Remodel Mask features a powerful blend of the latest age-reversal ingredients, including Methylene Blue, Growth Factors, Advanced Peptides, and Niacinamide.

Superfoods, robots and AI: innovation bursts onto the scene at Alimentaria & Hostelco

Retrieved on: 
星期二, 四月 2, 2024
Health, Fira de Barcelona, Gran Via, Vitamin D, Bread, Condiment, Intelligence, Diabetes, Food, Seed, Bubble tea, Mouth, Restaurant, Collagen, Drink, Fira

These products together with hundreds more were showcased during the event held in Barcelona (Spain) during March 18-21.

Key Points: 
  • These products together with hundreds more were showcased during the event held in Barcelona (Spain) during March 18-21.
  • The event that took place at Fira de Barcelona's Gran Via venue became a showcase for the food and hospitality industry of the future.
  • 3,200 companies exhibited their most innovative products, most of which were created in response to consumer concern for their health and well-being.
  • This edition, with more than 900 foreign companies, was the most international one held to date.

Superfoods, robots and AI: innovation bursts onto the scene at Alimentaria & Hostelco

Retrieved on: 
星期二, 四月 2, 2024
Health, Fira de Barcelona, Gran Via, Vitamin D, Bread, Condiment, Intelligence, Diabetes, Food, Seed, Bubble tea, Mouth, Restaurant, Collagen, Drink, Fira

These products together with hundreds more were showcased during the event held in Barcelona (Spain) during March 18-21.

Key Points: 
  • These products together with hundreds more were showcased during the event held in Barcelona (Spain) during March 18-21.
  • The event that took place at Fira de Barcelona's Gran Via venue became a showcase for the food and hospitality industry of the future.
  • 3,200 companies exhibited their most innovative products, most of which were created in response to consumer concern for their health and well-being.
  • This edition, with more than 900 foreign companies, was the most international one held to date.

Ready to Drink Beauty Beverage Market to Reach US$ 4,428.5 Million by 2034 Amid Growing Focus on Convenience and On-the-go Consumption

Retrieved on: 
星期二, 四月 9, 2024
Ginger, RTD, FMI, Health, Attention, Vital, Growth, Projection, Cranberry, Drink, Hibiscus, Hyaluronic acid, Sample, Beauty, Vitamin A, Zinc, Social media, Research, Protandim, Acquisition, CPG, Vitamin E, Social, Skin, Collagen, Biotin, Elasticity, Pomegranate, Supermarket, Ready, Food, Bottled water

NEWARK, Del., April 9, 2024 /PRNewswire/ -- According to Future Market Insights (FMI), the worldwide ready-to-drink beauty beverage market is valued at US$ 1,956.9 million in 2024 and is anticipated to reach US$ 4,428.5 million by 2034. Over the next decade, global ready to drink beauty beverages demand is likely to increase at a CAGR of 8.5%.

Key Points: 
  • NEWARK, Del., April 9, 2024 /PRNewswire/ -- According to Future Market Insights (FMI), the worldwide ready-to-drink beauty beverage market is valued at US$ 1,956.9 million in 2024 and is anticipated to reach US$ 4,428.5 million by 2034.
  • Over the next decade, global ready to drink beauty beverages demand is likely to increase at a CAGR of 8.5%.
  • Key Takeaways from the Ready to Drink Beauty Beverages Report:
    The global ready-to-drink beauty beverage market is expected to reach a valuation of US$ 4,428.5 million by 2034.
  • "The ready-to-drink beauty beverage market is experiencing growth due to health-conscious consumers seeking convenient and on-the-go beauty solutions.

Ready to Drink Beauty Beverage Market to Reach US$ 4,428.5 Million by 2034 Amid Growing Focus on Convenience and On-the-go Consumption

Retrieved on: 
星期二, 四月 9, 2024
Ginger, RTD, FMI, Health, Attention, Vital, Growth, Projection, Cranberry, Drink, Hibiscus, Hyaluronic acid, Sample, Beauty, Vitamin A, Zinc, Social media, Research, Protandim, Acquisition, CPG, Vitamin E, Social, Skin, Collagen, Biotin, Elasticity, Pomegranate, Supermarket, Ready, Food, Bottled water

NEWARK, Del., April 9, 2024 /PRNewswire/ -- According to Future Market Insights (FMI), the worldwide ready-to-drink beauty beverage market is valued at US$ 1,956.9 million in 2024 and is anticipated to reach US$ 4,428.5 million by 2034. Over the next decade, global ready to drink beauty beverages demand is likely to increase at a CAGR of 8.5%.

Key Points: 
  • NEWARK, Del., April 9, 2024 /PRNewswire/ -- According to Future Market Insights (FMI), the worldwide ready-to-drink beauty beverage market is valued at US$ 1,956.9 million in 2024 and is anticipated to reach US$ 4,428.5 million by 2034.
  • Over the next decade, global ready to drink beauty beverages demand is likely to increase at a CAGR of 8.5%.
  • Key Takeaways from the Ready to Drink Beauty Beverages Report:
    The global ready-to-drink beauty beverage market is expected to reach a valuation of US$ 4,428.5 million by 2034.
  • "The ready-to-drink beauty beverage market is experiencing growth due to health-conscious consumers seeking convenient and on-the-go beauty solutions.

Orphan designation: Bis-(3-deoxy-3-(4-(3-fluorophenyl)-1H-1,2,3-triazol-1-yl)-beta-D-galactopyranosyl) sulfane Treatment of idiopathic pulmonary fibrosis, 21/08/2020 Withdrawn

Retrieved on: 
星期二, 四月 9, 2024
Eurostat, Civil service commission, Diagnosis, Idiopathic pulmonary fibrosis, Disease, Patient, Committee, Knowledge, Regulation, EMA, IRIS, Hydrogen, IPF, European, Collagen, COMP, Oxygen, Urinary tract infection, Sponsor, European Commission, Safety, Blood, Marketing, Medicine, Pharmaceutical industry

Orphan designation: Bis-(3-deoxy-3-(4-(3-fluorophenyl)-1H-1,2,3-triazol-1-yl)-beta-D-galactopyranosyl) sulfane Treatment of idiopathic pulmonary fibrosis, 21/08/2020 Withdrawn

Key Points: 


Orphan designation: Bis-(3-deoxy-3-(4-(3-fluorophenyl)-1H-1,2,3-triazol-1-yl)-beta-D-galactopyranosyl) sulfane Treatment of idiopathic pulmonary fibrosis, 21/08/2020 Withdrawn

Orphan designation: (6aR, 10aR)-3-(1',1'-dimethylheptyl)-delta-8-tetrahydro-cannabinol-9-carboxylic acid Treatment of systemic sclerosis, 12/01/2017 Withdrawn

Retrieved on: 
星期二, 四月 9, 2024
Eurostat, Diagnosis, Civil service commission, Finger, Growth, Face, Blood, Disease, Inflammation, Patient, Committee, Knowledge, Regulation, Systemic scleroderma, EMA, IRIS, Protein, Scleroderma, CB2, European, Collagen, COMP, Connective tissue, Skin, Heart, Sponsor, European Commission, Immune system, The, Safety, Swelling, Marketing, Pharmaceutical industry

Orphan designation: (6aR, 10aR)-3-(1',1'-dimethylheptyl)-delta-8-tetrahydro-cannabinol-9-carboxylic acid Treatment of systemic sclerosis, 12/01/2017 Withdrawn

Key Points: 


Orphan designation: (6aR, 10aR)-3-(1',1'-dimethylheptyl)-delta-8-tetrahydro-cannabinol-9-carboxylic acid Treatment of systemic sclerosis, 12/01/2017 Withdrawn